Your browser doesn't support javascript.
loading
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
Fornaro, Lorenzo; Vivaldi, Caterina; Parnofiello, Annamaria; Ugolini, Clara; Aprile, Giuseppe; De Maglio, Giovanna; Pecora, Irene; Iacono, Donatella; Crivelli, Francesca; Catanese, Silvia; Cardellino, Giovanni Gerardo; Lencioni, Monica; Vasile, Enrico; Salani, Francesca; Clerico, Mario; Calvetti, Lorenzo; Falcone, Alfredo; Fasola, Gianpiero; Fontanini, Gabriella; Montagnani, Francesco.
Afiliación
  • Fornaro L; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. lorenzo.fornaro@gmail.com.
  • Vivaldi C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Parnofiello A; Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Ugolini C; Department of Laboratory Medicine, Section of Pathology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Aprile G; Department of Oncology, San Bortolo General Hospital, East District, Vicenza, AULSS8, Italy.
  • De Maglio G; Department of Pathology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Pecora I; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Iacono D; Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Crivelli F; Department of Oncology, Azienda Sanitaria Locale di Biella, Ponderano (BI), Italy.
  • Catanese S; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Cardellino GG; Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Lencioni M; Unit of Medical Oncology 1, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Vasile E; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Salani F; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Clerico M; Department of Oncology, Azienda Sanitaria Locale di Biella, Ponderano (BI), Italy.
  • Calvetti L; Department of Oncology, San Bortolo General Hospital, East District, Vicenza, AULSS8, Italy.
  • Falcone A; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Fasola G; Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Fontanini G; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Montagnani F; Department of Oncology, Azienda Sanitaria Locale di Biella, Ponderano (BI), Italy.
Br J Cancer ; 120(5): 522-526, 2019 03.
Article en En | MEDLINE | ID: mdl-30745584
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Carcinoma / Receptor ErbB-2 / Unión Esofagogástrica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Carcinoma / Receptor ErbB-2 / Unión Esofagogástrica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia